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INTRODUCTION
Autophagy is a cardinal cellular mechanism that involves the 
degradation and digestion of intracellular constituents by lysosomes 
[1-3]. Autophagy controls inflammation through interactions 
with immune signaling pathways and regulates the secretion of 
molecular mediators of inflammation [4-6]. Autophagy plays a 
vital role in the physiological conditions of many immune cells 
including macrophages [7-9]. Appropriate autophagy contributes 
to neuroprotection, whereas inappropriate autophagy could induce 
cell death [10-12]. Autophagy constitutes a lysosome-mediated 
degradation process [13] and is crucial for the maintenance 
of metabolic homeostasis by inhibiting the accumulation of 
misfolded proteins and of damaged cytoplasmic organelles [14-16]. 
Autophagy mitigates neurodegeneration caused by oxidative stress 
[17], whereas impaired autophagy signaling has been implicated 
in neurodegenerative disorders such as Parkinson’s, Alzheimer’s 
diseases[18-21], spinal cord injury [22], and stroke [23]. 
Autophagosome formation is controlled by protein complexes 
including the mammalian target of rapamycin (mTOR) complex 
1 (mTORC1) and the coiled-coil myosin-like BCL2-interacting 
protein 1 (Beclin 1)-complex [24-27]. The autophagy process 
is initiated by the regulation of protein complexes composed 
of more than 30 autophagy-related (ATG) proteins [28-30] 
and autophagic adaptor light chain 3 protein (LC3) [31]. The 
phosphatidylethanol-amine-conjugated LC3 (LC3II) is localized 
at the inner and outer autophagosomal membranes and plays a 
critical role for the initiation of autophagy process [31]. Autophagy 
can regulate the production and secretion of diverse cytokines in 
cells [32-34]. Microglia degrades beta-amyloid (Aβ) via autophagy 
miR-Let7A Modulates Autophagy  
Induction in LPS-Activated Microglia
Juhyun Song1, Yumi Oh1,2 and Jong Eun Lee1,2*
1Department of Anatomy, 2BK21 Plus Project for Medical Sciences, and Brain Research Institute,  
Yonsei University College of Medicine, Seoul 120-752, Korea
http://dx.doi.org/10.5607/en.2015.24.2.117
Exp Neurobiol. 2015 Jun;24(2):117-125.
pISSN 1226-2560 • eISSN 2093-8144
Original Article
Received April 30, 2015, Revised May 22, 2015,
Accepted May 25, 2015 
*To whom correspondence should be addressed.
TEL: 82-2-2228-1646, 1659, FAX: 82-2-365-0700
e-mail: jelee@yuhs.ac
Microglia regulate the secretion of various immunomediators in central nervous system diseases. Microglial autophagy is the 
crucial process for cell’s survival and cytokine productions. Recent studies have reported that several microRNAs are involved in the 
autophagy system. miR-Let7A is such a microRNA that plays a role in various inflammation responses, and is magnified as a key 
modulator particularly in the autophagy system. In present study, we investigated whether miR-Let7A is involved in autophagy in 
activating microglia. Overexpression of miR-Let7A in LPS-stimulated BV2 microglial cells promoted the induction of the autophagy 
related factors such as LC3II, Beclin1, and ATG3. Our results suggest a potential role of miR-Let7A in the autophagy process of 
microglia during CNS inflammation.
Key words: microRNA-Let7A (miR-Let7A), Microglia, Autophagy, Beclin 1, Microtubule-associated protein light chain 3 (LC3) II, 
ATG 3
Copyright © Experimental Neurobiology 2015.
www.enjournal.org
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and 
reproduction in any medium, provided the original work is properly cited.
118 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.2.117
Juhyun Song, et al.
in Alzheimer’s disease [35]. The decreased level of Beclin 1 and the 
blockade of microglial pahgocytosis were observed in Alzheimer’s 
disease patients [36,37].
Several microRNA (miR) are associated with autophagic 
flux [38]. The overexpression of miR-195[39], miR-14 [40], 
miRNA-30a [41] and miR-423-5p [42] promote induction of 
autophagy, whereas suppression of miR-101 induces autophagy in 
cardiomyocytes [43]. MicroRNA-Let7A (miR-Let7A) is a tumor 
suppressor miRNA that target transcription-related genes in 
apoptosis [44]. MiR-Let7A regulates anti-inflammatory responses 
through repression of specific genes acting in downstream 
signaling pathways [44] and is involved in the function of 
microglia in inflammatory injury. Notably, miR-Let7 promotes 
autophagy by suppression of mTOR signaling [45], and activates 
the neuronal autophagy in the brain of mice [46,47]. Moreover, 
the suppression of miR-Let7a in mice leads to the reduction of 
LC3 II levels [45]. In the present study, we investigated whether 
miR-Let7a controls autophagy process in microglia activated by 
lipopolysaccharide (LPS).
MATERIALS AND METHODS
BV2 microglia culture 
BV2 microglial cells were obtained from Prof. Eun-hye Joe (Ajou 
University School of Medicine, Chronic Inflammatory Disease 
Research Center). BV2 cells cultured in Dulbecco’s Modified Eagle’s 
Medium (Gibco, NY, USA) supplemented with 10% fetal bovine 
serum (Gibco, NY, USA) and 100 μg/ml penicillin-streptomycin 
(Gibco, NY, USA) at 37°C in a humidified atmosphere containing 
5% CO2. Lipopolysaccharide (LPS, 1 μg/ml; Sigma-Aldrich, St. 
Louis, MO, USA) was treated in BV2 microglia for 12 h before 
sampling.
miR- Let7A transfection 
Mmu-Let7A-5p (cat#, 4464066) was purchased from Ambion 
(Ambion, Austin, TX, USA). For the transfection of RNA duplexes, 
miR-Let7A mimic or miR-Let7A inhibitor was diluted to a 20 nM 
final concentration in Opti-MEM, and mixed with Lipofectamine 
2000 (Invitrogen, Carlsbad, CA, USA). After incubation at room 
temperature for 15 min, the mixture was added to cells. Cells 
were incubated for 72 h and harvested for total protein or RNA 
extraction. 
Reverse transcription PCR
Reverse transcription PCR was performed to measure mRNA 
levels of Beclin-1, LC3II in BV2 microglia. Briefly, cells were 
lysed with Trizol reagent (Invitrogen, Carlsbad, CA, USA), 
and total RNA was extracted according to the manufacturer’s 
Fig. 1. miR-Let7A overexpression upregulated LC3II mRNA level in BV2 microglia. (A) PCR data showing enhanced expression of LC3II mRNA level 
in microglia transfected with miR-Let7A mimic (20 nM). GAPDH was used as a control. (B) Western blotting showing LC3II protein levels in microglia 
transfected with miR-Let7A mimic. β-actin was used as a control. NC: normal control, Let7A overexpression: miR-Let7A overexpression. Data were 
expressed as mean±S.E.M, and each experiment included 3 repeats per condition. Differences were considered significant at *p<0.05 and **p<0.001.
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protocol. cDNA synthesis from isolated total RNA and sample 
normalization were performed. PCR was performed using the 
following thermal cycling conditions: 10 min at 95oC; 35 cycles 
of denaturing at 95oC for 15 sec, annealing for 30 sec at 62oC, 
elongation at 72oC for 30 sec; final extension for 10 min at 72oC, 
and held at 4oC. PCR was performed using the following primers (5' 
to 3'); Beclin-1: 5’-AGC TGC CGT TAT ACT GTT CTG-3’, (sense), 
and 5’-ACT GCC TCC TGT GTC TTC AAT CTT-3’, (antisense); 
LC3II: 5’-GAT GTC CGA CTT ATT CGA GAG C-3’, (sense), 
and 5’-TTG AGC TGT AAG CGC CTT CTA-3’ (antisense), 
GAPDH: GGC ATG GAC TGT GGT CAT GAG (sense), TGC 
ACC ACC AAC TGC TTA GC (antisense). PCR products were 
electrophoresed in 1.5% agarose gels and stained with ethidium 
bromide as described [48].
Western blot analysis
BV2 microglia were washed rapidly with ice-cold PBS, scraped, 
and collected. Cell pellets were lysed with ice-cold RIPA buffer 
(Sigma-Aldrich, St. Louis, MO, USA). The lysates were centrifuged 
at 12,000 rpm for 30 min at 4oC to produce whole-cell extracts. 
Protein content was quantified using the BCA method (Pierce, 
Rockford, IL, USA). Proteins (40 μg) were separated on a 
10% SDS–polyacrylamide (PAGE) gel and transferred onto a 
polyvinylidene difluoride (PVDF) membrane. After blocking with 
5% bovine serum albumin, prepared in Tris-buffered saline/Tween 
(TBS-T; 20 nM Tris [pH 7.2], 150 mM NaCl, and 0.1% Tween 
20), for 1 h at room temperature, immunoblots were incubated 
overnight at 4oC with primary antibodies that specifically detect 
Beclin-1 (1 : 1,000, Millipore, Billerica, MA, USA), ATG3 (1 : 
1,000, Abcam, Cambridge, MA, USA), LC3II (1 : 1,000, Cell 
Signaling Technology, Danvers, MA, USA), and β-actin (1 : 2,000, 
Cell Signaling Technology, Danvers, MA, USA). Next, blots were 
incubated with HRP-linked anti-rabbit IgG antibodies purchased 
from Abcam (Abcam, Cambridge, MA, USA) for 1 h 30 min at 
room temperature. Enhanced chemiluminescence was performed 
by ECL (Invitrogen, Carlsbad, CA, USA) [49].
Immunocytochemistry
The expression of Beclin1 and ATG3 in BV2 cells was examined 
by immunocytochemistry. Cells in all experimental groups were 
washed three times with PBS, fixed with 4% paraformaldehyde for 
3 h, and then washed with PBS. BV2 cells were permeabilized with 
0.025% Triton X-100 and blocked for 1 h at room temperature 
with dilution buffer (Invitrogen, Carlsbad, CA, USA). Primary 
antibodies, anti-rabbit-Beclin1 (1 : 500, Santa Cruz, CA, USA), and 
anti- rabbit-ATG3 (1 : 500, Santa Cruz, CA, USA) were prepared 
in dilution buffer, added to samples, and incubated for 3 h at 
room temperature. Primary antibody was then removed, and cells 
were washed 3 times for 3 min each with PBS. Next, samples were 
incubated with Rhodamine-conjugated goat anti-rabbit (1 : 200, 
Jackson Immunoresearch) for 1 h 30 min at room temperature. 
Cells were washed again three times for 3 min each with PBS and 
stained with 1 μg/mL 4',6-diamidino-2-phenylindole (DAPI) 
(1 : 100, Invitrogen, Carlsbad, CA, USA) for 15 min at room 
temperature. Fixed samples were imaged using a Zeiss LSM 700 
confocal microscope (Carl Zeiss, Thornwood, NY, USA) [49].
Statistical analysis
Statistical analyses were carried out using SPSS 18.0 software 
(IBM Corp., Armonk, NY, USA). All data are expressed as mean±S.
E.M. Significant intergroup differences were determined by one-
way analysis of variance (ANOVA) followed by Bonferroni post 
hoc multiple comparison test. Each experiment included at least 3 
replicates per condition. Differences were considered significant at 
*p<0.05, **p<0.001.
Fig. 2. miR-Let7A overexpression regulated Beclin 1 mRNA level in 
BV2 cells activated by LPS. The mRNA levels of Beclin 1 in normal BV2 
cells, BV2 cells transfected with miR-Let7A, BV2 cells treated with LPS 
(1 μg/ml), BV2 cells transfected with miR-Let7A and treated with LPS. 
LPS was treated for 12 h. GAPDH was used as a control. NC: normal 
control group, Let7A overexpression: miR-Let7A overexpression group, 
LPS: LPS treatment group. Data were expressed as mean±S.E.M, and each 
experiment included 3 repeats per condition. Differences were considered 
significant at *p<0.05, **p < 0.001.
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Fig. 3. miR-Let7A overexpression regulated Beclin 1, ATG3, LC3II protein levels in BV2 cells activated by LPS. (A~C) Western blotting showing the 
expression levels of Beclin 1 (A), ATG3 (B), and LC3II (C) and their quantifications in normal BV2 cells, BV2 cells transfected with miR-Let7A, BV2 cells 
treated with LPS (1 μg/ml), BV2 cells transfected with miR-Let7A and treated with LPS. miR-Let7A mimic was used at 20 nM and LPS was treated for 12 h. 
β-actin was used as a control. NC: normal control group, Let7A overexpression: miR-Let7A overexpression group, LPS: LPS treatment group. Data were 
expressed as mean±S.E.M, and each experiment included 3 repeats per condition. Differences were considered significant at *p<0.05, **p < 0.001. 
Fig. 4. Immunocytochemical analysis of ATG3 expression in miR-Let7A-transfected BV2 microglia activated by LPS. (A, B) Immunocytochemical 
images showing ATG3 immunoreactivity (green) in normal BV2 cells, BV2 cells transfected with miR-Let7A, BV2 cells treated with miR-Let7A 
inhibitor, BV2 cells treated with LPS (1 μg/ml), BV2 cells transfected with miR-Let7A and treated with LPS. miR-Let7A mimic was used at 20 nM and 
LPS was treated for 12 h. NC: normal control group, miR-Let7A overexpression: Let7A overexpression group, LPS: LPS treatment group, LPS+miR-
Let7A overexpression: LPS treatment plus miR-Let7A overexpression group, miR-Let7A inhibitor: miR-Let7A suppression group. Scale bar: 200 μm, 4', 
6-diamidino-2-phenylindole (DAPI): blue, ATG3: green. 
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RESULTS
The mRNA levels of LC3II in microglia were increased after 
miR-Let7A overexpression
LC3II (the microtubule-associated protein light chain 3) is 
the key element in the initial isolation membrane nucleation of 
autophagy process [50]. PCR analysis showed that the mRNA level 
of LC3II was increased in miR-Let7A-overexpressing BV2 cells 
(Fig. 1A). Western blot analysis confirmed that the protein level 
of LC3II in miR-Let7A-overexpressing BV2 cells was increased 
comparison to the normal group (Fig. 1B).
The overexpression of miR-Let7A modulated the expression 
of Beclin1 and ATG3 in inflammation-induced microglia 
The expression levels of  Beclin 1 transcripts (Fig. 2) and 
Beclin 1 protein (Fig. 3A) were slightly reduced in miR-Let7A-
overexpressing BV2 cells compared to those in normal BV2 cells. 
LPS-treated BV2 cells showed more profound reduction of Beclin 
1 transcripts and Beclin 1 protein (Fig. 2 and 3A). The miR-Let7A 
overexpression partially blocked reduced expression of Beclin 1 
transcripts and Beclin 1 protein in LPS-treated BV2 cells (Fig. 2 
and 3A). 
The ATG3 level was increased in miR-Let7A-overexpressing 
BV2 cells, whereas the ATG3 level was decreased in LPS-treated 
BV2 cells compared to that in normal BV2 cells (Fig. 3B). In LPS-
treated miR-Let7A-overexpressing BV2 cells, the ATG3 level was 
lower than that in normal BV2 cells, but it was higher than that in 
LPS-treated BV2 cells (Fig. 3B). 
The LC3II level was increased in miR-Let7A-overexpressing 
BV2 cells, whereas the LC3II was not significantly changed (Fig. 
3C). In LPS-treated miR-Let7A-overexpressing BV2 cells, LC3II 
level was higher than that in normal BV2 cells (Fig. 3C). 
Immunocytochemical analyses were performed to visualize 
the miR-Let7A-dependent regulation of ATG3 (Fig. 4) and 
Beclin 1 (Fig. 5) expressions in a cellular level. The miR-Let7A 
overexpression in BV2 cells increased the expression of ATG3, 
whereas LPS treatment suppressed ATG3 in BV2 cells (Fig. 4A). 
Overexpression of miR-Let7A partially recovered LPS-induced 
reduced expression of ATG3 (Fig. 4B). The overexpression of miR-
Let7A in LPS-stimulated BV2 cells also partially recovered LPS-
induced reduced expression of Beclin 1 (Fig. 5B). 
Considering that Beclin1 is crucial in the initiation and 
Fig. 5. Immunocytochemical analysis of Beclin 1 expression in miR-Let7A-transfected BV2 microglia activated by LPS. (A, B) Immunocytochemical 
images showing Beclin 1 immunoreactivity (green) in normal BV2 cells, BV2 cells transfected with miR-Let7A, BV2 cells treated with miR-Let7A 
inhibitor, BV2 cells treated with LPS (1 μg/ml), BV2 cells transfected with miR-Let7A and treated with LPS. miR-Let7A mimic was used at 20 nM and 
LPS was treated for 12 h. NC: normal control group, miR-Let7A overexpression: Let7A overexpression group, LPS: LPS treatment group, LPS+miR-
Let7A overexpression: LPS treatment plus miR-Let7A overexpression group, miR-Let7A inhibitor: miR-Let7A suppression group. Scale bar: 200 μm, 4', 
6-diamidino-2-phenylindole (DAPI): blue, Beclin 1: green.
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activation of autophagy [51,52] and ATG3 protein is essential in 
the formation of autophagic vesicles [53], these results suggest that 
miR-Let7A promotes the initiation and activation of autophagy in 
inflammation induced BV2 cells by increasing the level of Beclin 1 
and ATG3.
DISCUSSION 
Autophagy is an essential mechanism in degrading dysfunctional 
proteins and damaged mitochondria in cells [29,53-57]. 
Autophagy regulates inflammatory responses [58,59]. On the 
other hand, impairment in autophagy is harmful; it aggravates 
endoplasmic reticulum (ER) stress in cells [14,57,60] and is 
associated with neurodegeneration such as Alzheimer’s disease 
[61-63]. Microtubule-associated protein LC3II is located on the 
internal surface of autophagosomes [14]. Several studies suggest 
that upregulation of LC3II increases the autophagic flux and early 
autophagosome formation, which requires also Beclin 1 [64,65]. 
LC3II levels are reduced in the brain of anti-miR-Let7 treated 
Huntington’s disease mice [45]. These results, together with miR-
Let7-dependent induction of LC3II in BV2 cells (Fig. 3), support 
the notion that miR-Let7A plays a role in autophagy induction in 
microglia. 
Numerous studies have reported that Beclin1 is a key factor 
in the activation of the autophagy [51,52] and the initiation of 
autophagy by enhancing vesicle nucleation [66]. A pivotal role of 
Beclin1 in regulating autophagy in microglia has been described 
[67]. Considering that Beclin 1 is essential in autophagy [51,52], we 
speculate that miR-Let7A may boost the initiation and activation 
of microglial autophagy by up-regulating Beclin 1 against 
inflammatory stress. ATG3 is a component of autophagy-related 
ubiquitination-like systems [24] and functions as a regulator of 
cell survival [68] by generating the autophagic vesicle [53,69,70]. 
miR-Let7A partially increased ATG3 expression in LPS-treated 
BV2 cells (Fig. 3B). This result suggests that miR-Let7A promotes 
autophagy in microglia via up-regulating ATG3. 
Disruption of autophagy flux contributes to neuronal cell 
death in Alzherimer’s disease and Huntington disease [71,72]. 
Considering that several autophagic factors including LC3II, 
Beclin1, and ATG3 were regulated by miR-Let7A in activating 
microglia, miR-Let7A-depdent regulation of  microglial 
autophagy needs be studied in more detail in the context and 
neuroinflammation and neurodegeneration.
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